Home › Funds › EDGAR LOMAX CO/VA › CVS

EDGAR LOMAX CO/VA position in CVS

CVS HEALTH CORP · Consumer Staples

EDGAR LOMAX CO/VA reported holding 651,520 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$55.8M, representing 4.22% of its reported portfolio and ranking #4 among its reported holdings. EDGAR LOMAX CO/VA has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)651.52K sh
Reported value held$55.83M
Portfolio Weight4.22%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How EDGAR LOMAX CO/VA's CVS position evolved

EDGAR LOMAX CO/VA first disclosed a stake in CVS in Q3 2023 at 591,699 shares (US$41.3M). The position peaked in Q2 2025 at 1,206,825 shares, worth US$83.2M. Across 13 filings, EDGAR LOMAX CO/VA increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 651,520 shares valued at US$55.8M — a reduction of -9,000 shares quarter over quarter.. Notable position changes include a 64% increase in Q1 2024 (shares fell 25% over the following quarter), a 38% increase in Q1 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 591.70K $41.31M New
Q4 2023 566.44K $44.73M Reduce
Q1 2024 929.84K $74.16M Add
Q2 2024 914.68K $54.02M Reduce
Q3 2024 900.45K $56.62M Reduce
Q4 2024 886.83K $39.81M Reduce
Q1 2025 1.23M $83.08M Add
Q2 2025 1.21M $83.25M Reduce
Q3 2025 933.57K $70.38M Reduce
Q4 2025 912.70K $72.43M Reduce
Q1 2026 715.96K $51.42M Reduce
Q2 2026 660.52K $68.33M Reduce
Q3 2026 651.52K $55.83M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CVS and 13F data

CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CVS

All CVS fund holders →

FAQ

How long has EDGAR LOMAX CO/VA held CVS?

EDGAR LOMAX CO/VA has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EDGAR LOMAX CO/VA's current position in CVS?

As of Q3 2026, EDGAR LOMAX CO/VA holds 651.52K shares of CVS (CVS HEALTH CORP), valued at $55.83M, representing 4.22% of its reported portfolio and ranking #4.

Has EDGAR LOMAX CO/VA been buying or selling CVS?

In the latest 13F filing (Q3 2026), EDGAR LOMAX CO/VA reduced its position in CVS. The position peaked in Q2 2025 at 1.21M shares.

Which other funds hold CVS?

Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.